chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT REPORTED VERY SWOOLEN ,ERYTHEMATOUS SITE OF VACCINATION,WITH CROPS OF SMALL BLISTER AT SITE APPROX 3.5 CM DIAMETERPRURITUS AT SITE STARTED ON EVENING OF ADMINISTRATION AND SWELLIN APPEARED NEXT DAY
Administered a third dose to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (Administered a third dose to patients) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Administered a third dose to patients). At the time of the report, EXTRA DOSE ADMINISTERED (Administered a third dose to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Cold Sweat and racing heart followed by momentary loss of consciousness which was then followed with total loss of muscle control for 3.5 hours while laying immobilzed on bathroom floor. Could only turn head which resulted in vomiting.
About 8 to 9 days after getting first COVID vaccine shot I noticed a bright red rash about 3 inches in diameter at injection site. It feels a bit hard to touch and sore upon touching. Also warm to touch.
After receiving flu vaccine (not made aware of vaccine manufacturer) felt fine and went home on Tuesday. Thighs a little weak noted on Thursday. Friday am woke up and legs weak, able to walk but not long distances and this has continued. Dr. notified on Friday and called back Monday regarding follow up. Still waiting for anything further.
Information has been received from a published article. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient #19 of 32, a 16 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 16 year old female on an unspecified date was vaccinated with a dose of RECOMBIVAX HB (lot number, route and site not reported). There was no concomitant medication. On an unspecified date after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The patient also experienced symptoms of conjunctivitis, keratitis, sclerids and skin nodule. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02343, WAES # 1004USA02345 to WAES # 1004USA02357. A copy of the published article is attached as further documentation of the patient's experience.
Injection was admin'd by standing pharmacist; soreness at injection area didn't dissipate in the usual time; eventually progressed to bursitis-like symptoms in upper left arm extending to left hand on Sept 25//applied ice to arm and hand, took ibuprofen.
immune system disorder; This case was reported by a consumer via interactive digital media and described the occurrence of immune system disorder in an unspecified number of female patient who received HPV 16-18 (HPV vaccine) for prophylaxis.   On an unknown date, the patient received HPV vaccine at an unknown dose. On an unknown date, unknown after receiving HPV vaccine, the patient experienced immune system disorder. On an unknown date, the outcome of the immune system disorder was unknown.   It was unknown if the reporter considered the immune system disorder to be related to HPV vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received HPV vaccine and experienced damaged immune system. This case has been linked to case US2019AMR070839, reported by the same reporter.
SWELLING FROM SHOULDER TO ELBOW, INFECTION HAD TO GO TO EMERGENCY ROOM WAS TREATED WITH A ANTIBIOTIC SHOT AS WELL AS WITH A STERIOD AND PRESCRIPTION.
patient was given dose to of Pfizer vaccine early (dose 1 was given 12/21/2020), patient was seen at a vaccine clinic offsite and had checked no to question of "have you received any vaccinations within the last 2 weeks?"
Patient reports pain in LEFT upper arm, difficulty moving arm and pain extending down to fingers. Patient cannot sleep on affected arm and requires help dressing and brushing hair etc. that requires raising arm.
Pt woke up with a headache that was intermittent and treated with Excedrin. At 1600 on 8/14/2008 it became a 10/10 HA, bandlike across entire head with associated nausea, non-throbbing, no photo/phonophobia. 24 hrs later presented to ED with "worse headache of my life". LP was clear with 64 WBC, 3 RBC. Pt never febrile. Pt was asymptomatic after IV fluids, compazine, Benadryl, and Ativan. Pt treated emperically with IV Vancomycin and IV Ceftriaxone for 48 hrs. 8/22/08-records received for follow-up visit after 3 day hospitalization with C/O severe headache that worsened whenever he moved head around. DX: aseptic meningitis.
Resident noted with emesis x3 on day shift, afrebrile. Resident continues to have small amount of emesis. T. 100.5 went down to 99.6, P. 103 BP. 190/93 O2. 96% Dr. notified. Will continue to monitor.
per mom-pt fainted for a few seconds p/vax-followed by being very rigid-streched out arm & legs & opened eyes very wide (RN did not witness);
* not sure directly related to vaccine but was to vaccination?? Pt did not disclose any seizure disorders and when asked if pt had had prior adverse events from vaccines it was stated that sometime he got nervous, nauseous and would vomit.  immediately after injecting the vaccine the patient seemed fine, but was getting over excited having been given the vaccine (anxious) pt then went stiff and eye rolled back, I believe seizure. The  father wasn't surprised and said that it has occurred before with other injections/ blood draws. pt recovered within a minute or two and was lucid and reported that he was fine. I monitored the patient for 30 minutes and recommended to the father that the patient be seen regarding the event, and that subsequent vaccinations be given at the doctors office.
S/P Infant Moderna vaccine administered; approximately 15 minutes post vaccine, hives noted on face/back/arms; no tongue/ lip swelling. Lungs clear.  Hives started to fade @ approximately 6:16pm w/ no additional incident Patient leaves vaccine site accompanied by parent
Fever; Chills; Headache; I have both my eyes swollen; This is a spontaneous report received from a contactable consumer (reporting on himself). A 39-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported) via an unspecified route of administration in Arm Left on 20May2021 11:45, as 2nd dose, single dose for COVID-19 immunization. The patient medical history nad concomitant medications were not reported. Patient previously took first dose of BNT162B2 29Apr2021 11:45. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications the patient received within 2 weeks of vaccination. He had his second shot on 20May2021 11:45 and he went to fever, chills and headache until Saturday morning. 23May2021 late in the evening he noticed his eyes started swelling up a little bit; they went down a little bit and he went to bed; 24May2021 he woke up with swollen eyes again. He clarified that he already reported this information; but he was unable to obtain reference number from that report. He had questions regarding these side effects after the Pfizer Covid Vaccine and wanted to know about recommendation on taking histamines like Zyrtec Benadryl after the vaccine Response. Since the vaccination, the patient has tested for COVID-19. The outcome of the event i have both my eyes swollen was not recovered and for rest events was unknown.  Information about lot/batch number has been requested.
He has been vaccinated for a year and even with the booster he must of had a break threw case. He was swabbed Saturday and has Covid; Bad sinus stuff and they did a PCR test and it came back positive for covid/he had a bad sore throat; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1, single (Lot number: EN6206), on 03Apr2021 as dose 2, single (Lot number: ER8727), on 12Nov2021 as dose 3 (booster), single (Lot number: FM8020) and on 21Apr2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 67 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing). The patient's family history included: "Diabetes" (unspecified if ongoing), notes: Mother passed away years ago, she was a diabetic. Concomitant medication(s) included: OLMESARTAN table once a day taken for blood pressure abnormal; AMLODIPINE 5mg once a day in the evening taken for blood pressure abnormal; CARVEDILOL 6.25mg twice a day taken for blood pressure abnormal; VITAMIN D [COLECALCIFEROL]; FISH OIL. Vaccination history included: Flu shot (got a flu shot last year, no further details provided). The following information was reported: COVID-19 (medically significant) with onset 18Jun2022, outcome "unknown", described as "Bad sinus stuff and they did a PCR (Polymerase chain reaction) test and it came back positive for covid/he had a bad sore throat"; VACCINATION FAILURE (medically significant) with onset 18Jun2022, outcome "unknown", described as "He has been vaccinated for a year and even with the booster he must of had a break threw case. He was swabbed Saturday and has Covid". The events "he has been vaccinated for a year and even with the booster he must of had a break threw case. he was swabbed Saturday and has covid" and "bad sinus stuff and they did a PCR test and it came back positive for covid/he had a bad sore throat" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: He tested positive (nasal swab) on Saturday, he had a bad sore throat. He went to PRIVACY for bad sinus stuff, and they did a PCR test and it came back positive for covid. Patient confirmed that he did not seek medical attention for worsening symptoms. His doctor called him on Monday and suggested to take Paxlovid. His doctor had a discussion about side effects and all this other stuff and told him to read all the materials before taking it. He started treatment with Paxlovid (Batch/lot number: GA9816), for a total of 3 tablets by mouth for COVID-19. He only took the one dose last night (1 tablet) on 20Jun2022 and that was it, stated he was stopping it now. His doctor told him he should start feeling better within a couple of days. Discontinued Paxlovid due to adverse events.
Overall pain; Fever; Stomach issue; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th November 2020, the patient received the 1st dose of Shingrix. In November 2020, less than a week after receiving Shingrix, the patient experienced general body pain, fever and stomach discomfort. On an unknown date, the outcome of the general body pain, fever and stomach discomfort were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, fever and stomach discomfort to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age at vaccination was not reported but was captured as an adult as per vaccine indication. The patient was curious how long overall pain, fever and stomach issue might last.
Neurosensory Hearing loss of left ear, sudden onset, Tinnitus, left ear
1 month after MMR vaccine, patient developed thrombocytopenia. Required ? and hospitalization. This is ongoing. Chronic ITP.
Swelling of lymph nodes along left clavicle starting approx 18 hours after injection.  No treatment, swelling reduced over the next few days
AM of 1/12 noticed hives like rash on right arm at site of injection. Rash spread to trunk, back, shoulders, then face. Stated it took 6 days to resolve. Experienced no difficulty breathing. No fever, No medications taken for relief of rash. Did not consult a physician. Called & requested a VAERS report submitted.
Fever of 100.9 F, aches all over (like flu symptoms) on evening of vaccination. This continued for 24 hours. On 2nd day post-vaccination, had a knot in muscle of administration with localized, non-pruritic rash of red, splotchy areas with muscle tenderness/soreness.
On the 1st day after shot her arm was really sore, and itching. The "itchy" feeling moved up her arm, neck, and jaw. The feeling moved into ears and lymph nodes causing dizziness. She went to ER on Monday Sept. 30th. She lost hearing in left ear. She lost ability to move facial muscles and left eye. She was hospitalized from Monday Septem, 30th to Wednesday Oct. 2nd. She states doctor performed CAT scan to check for stroke. Patient states doctors told her it was not a stroke. Patient is still unable to move left side of face, and is still unable walk without dizziness.
pt recv vax & c/o flu sx for 24hr p/vax;T100.4 w/body aches-no site edema-redness last Td @ least >12hr ago;sx resolved;
Very sore left arm, decreased range of movement, sharp pain, in upper arm, inability to sleep on left side.
Aura migraines lasting 3+ days, GI issues including diarrhea and nausea, extreme tiredness, excessive sleeping (12+ hours for 3 days consecutively), loss of appetite, inability to focus, feelings of depression and helplessness
Patient received 0.5ml on 4th booster shot (immunocompromised) when should have received 0.25ml
3-4 days p/receiving immun pt had jerking movements in arms & legs; called MD was told muscle spasms; sx reoccurred; MD dx sz;
So, it started with the chills about 9:30PM and it lasted a while because I was trying to sleep, all of the sudden the chills stop, and I was hot with fever. I was sweating and it seemed like it was rotating from chills to fever, and at the same night I had heart beating. Around 2:00 AM I started wheezing along with the fast heart beating. I was scared so I called a nurse that is through my insurance, and she said that it was a rapid heard beat but not necessary to go to the ER; she also said to take my albuterol.  The next morning, I felt fatigue and I was okay within the third day.
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Chest cough), PAIN (Body aches) and PYREXIA (Fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced COUGH (Chest cough), PAIN (Body aches) and PYREXIA (Fever). At the time of the report, COUGH (Chest cough), PAIN (Body aches) and PYREXIA (Fever) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included unspecified cough syrup.
severe and debilitating nerve and joint pain and extreme weakness starting in right leg and over the next few weeks spreading to other leg, arms and other parts of body. Still seeking treatment. Blood work and X-rays have returned normal.
fever/high fever; severe headache; urobilinogen and ketones in his urine; urobilinogen and ketones in his urine; urine was also dark in color; This is a spontaneous report from a contactable physician.    A male patient of an unspecified age received the first dose of  meningococcal group b rlp2086 (TRUMENBA) , via an unspecified route of administration on an unspecified date at single dose for immunisation , the second dose of meningococcal vaccine a/c/y/w (MENINGOCOCCAL VACCINE A/C/Y/W) , via an unspecified route of administration on an unspecified date at single dose for immunisation .  The patient medical history and concomitant medications were not reported.  The patient previously took the first dose of meningococcal vaccine a/c/y/w for immunisation on an unknown date.  The patient experienced high fever  on an unspecified date with outcome of unknown , severe headache on an unspecified date with outcome of unknown , urobilinogen and ketones in his urine on an unspecified date with outcome of unknown , urine was also dark in color on an unspecified date with outcome of unknown. The reported events were considered non serious. The patient underwent lab tests and procedures which included urine analysis: urobilinogen and ketones    on unknown date,  body temperature: pyrexia on an unknown date.  His urine was also dark in color.  The information on the batch number has been requested
Injection site pain - present Tiredness - 24hrs Headache - 24 hrs Muscle pain - 24 hrs Chills - 24 hrs  Joint pain - 24 hrs Fever (101.2°f) - 24 hrs Nausea - 24 hrs  Malaise - 24 hrs  Swollen lymph node (left armpit only) - present
Patient had Moderna Vaccine dose #1 administered and was waiting for approximately 15 min in the post vaccination area. She stated to the nurses in the area she was feeling light headed and dizzy @ approx. 12:23pm.  Nurses arrived on scene with Emergency kit and stretcher.  EMS called at 12:24pm by security team.  Vitals 125/81 pulse 71. She appeared diaphoretic.  Patient denied any type of anaphylactic reaction, denies any difficulty breathing, shortness of breath, fast heart rate, closing of the throat, itching or generalize rash. Denies any medical history, or current medications. Allergies to PCN (rash).  States she has a history of vasovagal syncope in stressful situations. Vitals at 12:27pm 119/75 pulse 79 EMS arrived 12:34pm. Patient with stable vital signs, Alert oriented x 3. Upon arrival of EMS patient refused to be transported to hospital stating this has happened to her before. She denies any SOB, chest pain, palpitations, allergic reactions. She refused to have any friends or family members contacted stating she was ok.  She was advised not to drive however she refused medical advice. No medications or supplemental oxygen was needed during this encounter.
paint is having pain at injections site, flu like symptoms, and says pain in her spine which happens when she is sick and has muscle aches
Sore throat, followed by chills, fever, loss of appetite.  Symptoms lasted for four days.
Area (left upper arm) where vaccine was administered was very swollen and tender to touch.  Patient was unable to lift arm due to the pain.  Put ice on the area and took advil.  Was unable to sleep comfortably due to the pain in arm; on 09/02/2016 the area was still swollen and was difficult for patient to lift arm to get tops on and off.  09/03/2016 the area was no longer swollen and able to lift arm, however still tender to touch.
Day 8- large swollen area (size of a baseball) at injection site. Red, hot to touch, very itchy. Achy from elbow to shoulder.
patient came in on 4/17/21 to get her first dose of covid-19 Pfizer vaccine.  She stated and marked on consent form she had not received any other COViD vaccines.  She received her for pfizer vaccine on 4/17/21 at pharmacy and returned on 5/6/21 for her second dose of pfizer.  when we tried to bill her ins on 7/19/21 for pfizer vaccine it rejected stating to use same manufacturer as first dose.  Called insurance company and they stated that Moderna vaccines were billed from a different Pharmacy.  I spoke with patient on 7/19/21 and she initially said she did get both manufacturers; but when I asked why she got both of them she denied that she got both and only received the pfizer vaccine at the first pharmacy.  I call the other Pharmacy and spoke with the pharmacist.  He looked at the consent form they have and said it appears she signed the consent form and two doses of Moderna vaccines were given.  My pharmacy practice coordinator said to go ahead and submit this information to VAERS.
This spontaneous report as received from a consumer refers to a teenager patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL (dose, frequency, route of administration, lot# and expiration date were not reported) or a dose of GARDASIL 9 (dose, frequency, route of administration, lot# and expiration date were not reported). It was unknown if product was GARDASIL or GARDASIL 9. On an unknown date, the patient experienced adverse event unspecified. The outcome of adverse event was unknown. The relatedness between the adverse event and therapy with GARDASIL or GARDASIL was not reported. This is one of six reports received from the same source.; Sender's Comments: US-009507513-1712USA014392: US-009507513-1712USA014393: US-009507513-1712USA014394: US-009507513-1712USA014395: US-009507513-1712USA014396:
Administration error - Patient given first dose of Moderna vaccine 3 weeks before 18th birthday so outside of EUA criteria. Received second dose on 2/19/21 after his 18th birthday.
An hour after receiving the vaccination, I developed a massive lump in my arm, with soreness and redness. Growing concerned I did online research to potentially see what was going on, and following the suggestions from websites- even CDC, I was led to believe that swelling is a normal experience for the vaccination. So a month goes by from the vaccination date, October 23 and the soreness and lump still has not gone down. Still following the advice online, it was suggested that "swelling" can take even up to 3 months to go down. Waiting for the 3 months, it is now January 2021 and I still have the lump in my arm and the arm is still sore, and noticeably more tired and quick to become tired and weak than my right arm, where I have not received the vaccination. At this, I scheduled an appointment at my local clinic to see what is going with my arm. The doctor ordered a Sonagram for my arm.  Even though it was ordered in February, their only  available appointment was in April. Once receiving my sonagram, it was found to have: hypoechoic area in the subcutaneous plane with heterogenous echotexture suggesting complexity. This may be related to a complex seroma versus hematoma. This mass developed after receiving the vaccination- as I did not have this mass nor diagnosis prior to receiving the vaccination.